These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 28949987)

  • 1. How much will it cost to eradicate lymphatic filariasis? An analysis of the financial and economic costs of intensified efforts against lymphatic filariasis.
    Kastner RJ; Sicuri E; Stone CM; Matwale G; Onapa A; Tediosi F
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005934. PubMed ID: 28949987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What Is Needed to Eradicate Lymphatic Filariasis? A Model-Based Assessment on the Impact of Scaling Up Mass Drug Administration Programs.
    Kastner RJ; Stone CM; Steinmann P; Tanner M; Tediosi F
    PLoS Negl Trop Dis; 2015; 9(10):e0004147. PubMed ID: 26451729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling the cost of engage & treat and test & treat strategies towards the elimination of lymphatic filariasis in Ghana.
    Adams NNK; Ahorlu CS; de Souza DK; Aikins M
    PLoS Negl Trop Dis; 2024 May; 18(5):e0012213. PubMed ID: 38787898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007).
    Chu BK; Hooper PJ; Bradley MH; McFarland DA; Ottesen EA
    PLoS Negl Trop Dis; 2010 Jun; 4(6):e708. PubMed ID: 20532228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic performance and cost-effectiveness of using a DEC-salt social enterprise for eliminating the major neglected tropical disease, lymphatic filariasis.
    Sharma S; Smith ME; Reimer J; O'Brien DB; Brissau JM; Donahue MC; Carter CE; Michael E
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007094. PubMed ID: 31260444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Financial and Economic Costs of the Elimination and Eradication of Onchocerciasis (River Blindness) in Africa.
    Kim YE; Sicuri E; Tediosi F
    PLoS Negl Trop Dis; 2015; 9(9):e0004056. PubMed ID: 26360917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Thailand eliminated lymphatic filariasis as a public health problem.
    Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
    Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing the Antigen Prevalence Target Threshold for Stopping and Restarting Mass Drug Administration for Lymphatic Filariasis Elimination: A Model-Based Cost-effectiveness Simulation in Tanzania, India and Haiti.
    Antony Oliver MC; Graham M; Gass KM; Medley GF; Clark J; Davis EL; Reimer LJ; King JD; Pouwels KB; Hollingsworth TD
    Clin Infect Dis; 2024 Apr; 78(Supplement_2):S160-S168. PubMed ID: 38662697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000-2014).
    Turner HC; Bettis AA; Chu BK; McFarland DA; Hooper PJ; Ottesen EA; Bradley MH
    Infect Dis Poverty; 2016 May; 5(1):54. PubMed ID: 27388873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling the health impact and cost-effectiveness of lymphatic filariasis eradication under varying levels of mass drug administration scale-up and geographic coverage.
    Stone CM; Kastner R; Steinmann P; Chitnis N; Tanner M; Tediosi F
    BMJ Glob Health; 2016; 1(1):e000021. PubMed ID: 28588916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons from lymphatic filariasis elimination and the challenges of post-elimination surveillance in China.
    Fang Y; Zhang Y
    Infect Dis Poverty; 2019 Aug; 8(1):66. PubMed ID: 31387644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National mass drug administration costs for lymphatic filariasis elimination.
    Goldman AS; Guisinger VH; Aikins M; Amarillo ML; Belizario VY; Garshong B; Gyapong J; Kabali C; Kamal HA; Kanjilal S; Kyelem D; Lizardo J; Malecela M; Mubyazi G; Nitièma PA; Ramzy RM; Streit TG; Wallace A; Brady MA; Rheingans R; Ottesen EA; Haddix AC
    PLoS Negl Trop Dis; 2007 Oct; 1(1):e67. PubMed ID: 17989784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination.
    Nana-Djeunga HC; Tchouakui M; Njitchouang GR; Tchatchueng-Mbougua JB; Nwane P; Domche A; Bopda J; Mbickmen-Tchana S; Akame J; Tarini A; Epée E; Biholong BD; Zhang Y; Tougoue JJ; Kabore A; Njiokou F; Kamgno J
    PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005633. PubMed ID: 28662054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards elimination of lymphatic filariasis in southeastern Madagascar: Successes and challenges for interrupting transmission.
    Garchitorena A; Raza-Fanomezanjanahary EM; Mioramalala SA; Chesnais CB; Ratsimbasoa CA; Ramarosata H; Bonds MH; Rabenantoandro H
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006780. PubMed ID: 30222758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative Surveys.
    Krentel A; Damayanti R; Titaley CR; Suharno N; Bradley M; Lynam T
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005027. PubMed ID: 27812107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis.
    Stolk WA; ten Bosch QA; de Vlas SJ; Fischer PU; Weil GJ; Goldman AS
    PLoS Negl Trop Dis; 2013; 7(1):e1984. PubMed ID: 23301115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous dynamics, robustness/fragility trade-offs, and the eradication of the macroparasitic disease, lymphatic filariasis.
    Michael E; Singh BK
    BMC Med; 2016 Jan; 14():14. PubMed ID: 26822124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease.
    Ramaiah KD; Ottesen EA
    PLoS Negl Trop Dis; 2014 Nov; 8(11):e3319. PubMed ID: 25412180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass drug administration to eliminate lymphatic filariasis in India.
    Ramaiah KD; Das PK
    Trends Parasitol; 2004 Nov; 20(11):499-502. PubMed ID: 15471698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling lymphatic filariasis elimination in American Samoa: GEOFIL predicts need for new targets and six rounds of mass drug administration.
    McLure A; Graves PM; Lau C; Shaw C; Glass K
    Epidemics; 2022 Sep; 40():100591. PubMed ID: 35816826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.